Question 1

What is ABVC Biopharma Inc (ABVC) stock price today?

Accepted Answer

ABVC Biopharma Inc (ABVC) currently trades at $1.03 per share. The stock has a market capitalization of $26.41M and a P/E ratio of —x.

Question 2

Is ABVC stock a buy, sell, or hold in 2026?

Accepted Answer

Based on WallStSmart's proprietary analysis, ABVC Biopharma Inc has a Smart Value Score of 38/100 (Grade D), resulting in a "Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

Question 3

What is ABVC Biopharma Inc's revenue and earnings?

Accepted Answer

ABVC Biopharma Inc has trailing twelve-month (TTM) revenue of $797920.00 with profit margins of 0.00%. Earnings per share (EPS) is $-0.39.

Question 4

Is ABVC stock overvalued or undervalued?

Accepted Answer

Based on our DCF model, ABVC Biopharma Inc's intrinsic value is $5.82, representing a margin of safety of 70.27%. The stock currently trades at a P/E of —x.

Metric	2022	2023	2024	2025	TTM
Revenue	$969783.00	$152430.00	$509589.00	$795950.00	$797920.00
Net income	$-16.42M	$-7.79M	$-4.90M	$-7.91M	$-3.56M
EPS	—	—	—	—	$-0.39
Free cash flow	$-7.52M	$-4.21M	$-1.81M	$-2.99M	$-587582.00
Profit margin	-1,693.50%	-5,109.26%	-962.12%	-993.60%	—

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
ABVC	$26.41M	38	5.3	4.5	6.7	5.0	+70.27%	Hold
LLY	$789.69B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.64B	59	4.7	9.0	3.3	6.0	-41.97%	Buy
ABBV	$351.47B	63	4.0	8.0	4.7	5.0	-24.92%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

ABVC Biopharma Inc

WallStSmart proprietary scores

Price targets

Price chart

X-Ray snapshot

Key financials

Peer comparison

Smart narrative

Frequently asked questions

Company info

Quick metrics

Performance

Compare